Euromedia24 on Play Store Euromedia24 on App Sore
BNB

$870.47

BTC

$113082

ADA

$0.868816

ETH

$4608.63

SOL

$213.76

31 °

Yerevan

20 °

Moscow

45 °

Dubai

20 °

London

26 °

Beijing

23 °

Brussels

16 °

Rome

23 °

Madrid

BNB

$870.47

BTC

$113082

ADA

$0.868816

ETH

$4608.63

SOL

$213.76

31 °

Yerevan

20 °

Moscow

45 °

Dubai

20 °

London

26 °

Beijing

23 °

Brussels

16 °

Rome

23 °

Madrid

Scientists have developed a MRNA vaccine against the loss of age vision


Scientists from the Institute of Science of Tokyo have developed a MRNA vaccine that can prevent the loss of vision due to age-yellow stain degeneration (DBD). The results of the study were published in the journal Vaccines.

DBD is one of the main causes of vision loss, which affects almost 200 million people around the world. This chronic disease affects the central part of the retina (DBD), which is responsible for simple and detailed vision.

The new vaccine operates, suppressing neuascularism, the abnormal growth of blood vessels in the retina, which leads to a gradual loss of fluid accumulation and vision. Regular injections of anti-Azerbaijani drugs are currently used to slow down this process. However, such procedures require frequent repetition and are not always effective in the long run.

The vaccine developed by Japanese scientists is based on MRNA encoding LRG1 protein. This protein is connected with the development of abnormal blood vessels in the case of DBD. After the interface injection, the body begins to produce antibodies against this protein, which block the growth of abnormal vessels without affecting healthy tissue.

During the tests on two groups of mice, two injections of the drug were significantly reduced the level of retinal damage to 85%, in the indicated IMA model and up to 55%, in a natural model. The first positive results were viewed within a week after the first dose.

Scientists say the vaccine has shown high security. It has not caused side effects and does not disrupt the retinal blood flow.

"If the effectiveness of this new vaccine is confirmed in clinical trials, it will pass the way to the MCA's more convenient and less traumatic injection instead of ordinary eye injections," said Sautoshi Uchid.

Translation of: Euromedia24.com

News

California Prepares for Storms and Flooding Ahead of Thanksgiving Day (Photos)
Artificial Intelligence Could Help Humans Live Up to 1,400 Years
What Hrant Tokhatyan Looks Like After a Prolonged Illness (Photo)
The Georgian Government Has Decided to Ban Surrogacy
Thousands Protest in Lisbon Under Torrential Rain Over Price Increases and Housing Crisis (Photos)
People Poisoned by Carbon Monoxide in Church in Germany
Chain Accident Near Yerevan Lake: There Are Casualties and Injuries
Evacuation carried out at Tromsø Airport in Norway: What is known
In Yakutia, a man killed his 15-year-old stepson, injured his 14-year-old son, attacked his wife, and then committed suicide
Details Emerge on the Death of Former Head of Italy’s Police
Snowfall in Vardenis, Martuni, Ashotsk regions
Ara Gevorgyan's "Artsakh" Composition Performed on Georgia's X Factor TV Show (Video)
Two 15-Year-Old Students of Ararat State College Went to Class with a Pistol and a Knife with a Hidden Lock
Vladimir, this is unacceptable. Italy's Prime Minister criticized Zelensky
In Lernavan, a ruling party MP insulted a villager during a campaign; a scuffle ensued, says Ioannisyan
Major fire breaks out at a confectionery factory in Indonesia; there are casualties
Belgium to Close Its Airspace for 14 Hours Due to Strike
In Talin, Police Officers and Two Young Men Rescued a Russian Citizen and Six Family Members from a Fire in a Nissan
Precipitation Expected in the Republic; Air Temperature to Decrease
Final lists published for Local Self-Government elections to be held on November 29